Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
ileus, intestinal obstruction, severe constipation including fecal impaction, nausea, vomiting and diarrhea leading to dehydration Hepatobiliary Hyperbilirubinemia, elevations of liver enzymes, cholestasis and hepatitis Hypersensitivity Rash, pruritus, angioedema and anaphylactic reactions Neoplasms Medullary thyroid carcinoma Neurologic Dysesthesia, headache Pulmonary Pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation
What is the recommended dosage
Insurance coverage for weight loss medications can vary widely between plans
On their own, this user is self-prescribing the maximum approved dose of tirzepatide and is also taking unregulated retatrutide, a drug that has not been approved for human use because it it still in clinical trials
Scientific References Retatrutide Phase 2 obesity trial GLP-1/GIP/glucagon triple agonist (Jastreboff et al., Eli Lilly)
